Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
Type
Guidance (797)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (797)
Apply filters
Showing 491 to 500 of 797
Sort by
Date
Title
Apply sorting
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
TA161
27 October 2008
7 February 2018
Pirfenidone for treating idiopathic pulmonary fibrosis
TA504
6 February 2018
6 February 2018
Intrabeam radiotherapy system for adjuvant treatment of early breast cancer
TA501
31 January 2018
31 January 2018
Ibrutinib for treating relapsed or refractory mantle cell lymphoma
TA502
31 January 2018
31 January 2018
Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer
TA503
31 January 2018
31 January 2018
Lenvatinib with everolimus for previously treated advanced renal cell carcinoma
TA498
24 January 2018
24 January 2018
Glecaprevir–pibrentasvir for treating chronic hepatitis C
TA499
24 January 2018
24 January 2018
Ceritinib for untreated ALK-positive non-small-cell lung cancer
TA500
24 January 2018
24 January 2018
Golimumab for treating non-radiographic axial spondyloarthritis
TA497
10 January 2018
10 January 2018
Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
TA495
20 December 2017
20 December 2017
Previous page
1
…
48
49
Current page
50
51
52
…
80
Page
50
of
80
Next page
Results per page
10
25
50
All
Back to top